학술논문
Ipragliflozin, a SGLT2 Inhibitor, Reduced Body Weight and Fat Mass but Not Muscle Mass in Japanese Type 2 Diabetic Patients Treated with Insulin-A Randomized Clinical Trial
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
1939327X